Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-27

Well we would be looking at a 10.5c SP if the clinic had decided not to continue use DX. That would have happened if RAP insisted on a paid contract at this stage is my guess. Today's announcement by TK and comments below by Dr Evan Jones provides validation. I have said in the past that the monetisation for RAP via the Gov funded Respiratory Clinics would be via a Fed Government Grant eg 10 mill would do the trick for a Nationwide usage licence for 12 months I mean they gave 5mil to for a pain detection app didnt they??and arent we in the biggest 100 year worldwide repository disease pandemic?? i recon its worth every cent.

“ResAppDx is a revolutionary tool for triaging respiratory patients,” said Dr Evan Jones, Director of Health Hub Doctors Morayfield and Adjunct Associate Professor of the University of the Sunshine Coast. “Our clinicians have found the test very useful in both confirming their suspected diagnosis as well as identifying cases otherwise not detected by a physical examination.” “We are pleased to see the clinic find ResAppDx both useful and accurate in the evaluation of patients with respiratory symptoms during the COVID-19 pandemic,” added Tony Keating, CEO and Managing Director of ResApp. “The continued use of ResAppDx in the clinic is providing us with valuable real-world evidence on the benefits of ResAppDx, and the clinic has additionally agreed to share and publish this evidence with the medical community.”